New York, NY, United States of America

P J Klasse

This inventor holds 1 USPTO granted patent. Top assignees: Cornell University, International Aids Vaccine Initiative, Scripps Research Institute. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: P J Klasse. Retrieved from https://idiyas.com/inventor/p-j-klasse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: P J Klasse: Innovator in HIV Research

Introduction

P J Klasse is a notable inventor based in New York, NY, who has made significant contributions to the field of HIV research. His work focuses on the development of novel HIV-1 envelope glycoproteins, which play a crucial role in vaccine development and immunological studies.

Latest Patents

P J Klasse holds a patent for his invention related to HIV-1 envelope glycoproteins. This patent, which is aimed at creating immunogenic compositions for vaccines, is essential for the identification of broad neutralizing antibodies. The patent emphasizes the preparation and purification of these glycoproteins, which can be utilized in various biophysical and biochemical studies.

Career Highlights

Throughout his career, P J Klasse has been associated with prominent organizations such as the International Aids Vaccine Initiative and The Scripps Research Institute. His work in these institutions has furthered the understanding of HIV and contributed to the development of potential vaccines.

Collaborations

P J Klasse has collaborated with esteemed colleagues, including Michael P Caulfield and Albert Cupo. These partnerships have enhanced the research efforts in the field of HIV and have led to significant advancements in vaccine development.

Conclusion

P J Klasse's innovative work in HIV research and his patent for HIV-1 envelope glycoproteins highlight his commitment to advancing medical science. His contributions are vital for the ongoing fight against HIV and the development of effective vaccines.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…